Type I photosensitizer-responsive self-immolative polymers: combining drug release with photodynamic therapy

˙) generated from type I photosensitizers (PSs). This process enables controlled drug release and type I photodynamic therapy (PDT) to amplify tumor-cell cytotoxicity, providing a platform that combines self-immolative polymer delivery systems with type I PDT.